The key finding
A 2025 analysis in Trends in Genetics highlights that recent computational and experimental advances have uncovered thousands of previously unknown microproteins—exceptionally small proteins produced by microbes living in and on the human body. These molecules, which had long escaped detection due to their diminutive size, are now being recognized as potential candidates for developing new antibiotics. The discovery is particularly timely as antibiotic resistance continues to threaten global health, with existing drugs losing effectiveness against common bacterial infections.
What the study looked like
This was a review article examining recent research developments rather than a single experimental study. The authors synthesized findings from multiple studies that used advanced computational prediction tools and improved experimental detection methods to identify microproteins across diverse microbial species. The focus was on microproteins found within the human microbiome—the vast community of bacteria, fungi, and other microorganisms inhabiting our gut, skin, and other body sites. Traditional protein-detection methods often missed these molecules because they are encoded by very short genetic sequences that researchers historically ignored or filtered out as noise. New bioinformatics approaches and mass spectrometry techniques have now made it possible to systematically catalog these small proteins that were hiding in plain sight.
Why researchers think this happened
The authors propose that microproteins have remained undetected for so long because standard gene-finding algorithms were designed to identify typical protein-coding genes, which are usually much longer. Microproteins are encoded by short open reading frames that were often dismissed as non-functional. The recent explosion of discoveries stems from improved computational tools that can predict these small genes and better laboratory methods that can detect their protein products. Researchers believe many of these microproteins evolved as chemical weapons in the competitive microbial ecosystems of the human body, where different bacterial species constantly vie for resources and territory. This ecological warfare may have produced molecules with natural antibiotic properties—compounds that kill or inhibit competing bacteria. Previous work has shown that the microbiome is a rich source of bioactive molecules, and microproteins appear to represent an untapped dimension of this chemical arsenal.
How to read this carefully
This is a review article summarizing emerging research rather than reporting new experimental data, so readers should understand it represents a synthesis of early-stage findings across multiple studies. The identification of microproteins as antibiotic candidates is still in preliminary phases—most have not been tested in clinical settings or even in animal models. The path from discovering a molecule with antibacterial properties in laboratory dishes to developing a safe, effective human medication typically takes many years and most candidates fail along the way. Additionally, the review does not specify exactly how many microproteins have been tested for antibiotic activity versus how many have simply been detected and characterized structurally. The human microbiome varies considerably between individuals, so findings in one population may not generalize universally.
What this means for everyday life
While we should not expect microprotein-based antibiotics at the pharmacy anytime soon, this research highlights how the microbes living in our bodies may hold solutions to pressing medical challenges. For those concerned about antibiotic resistance—which makes common infections harder to treat—this discovery suggests scientists are exploring creative new places to find therapeutic molecules rather than just modifying existing drug classes. It also underscores the value of maintaining a diverse, healthy microbiome through balanced diet and judicious antibiotic use, as this microbial community may be a reservoir of undiscovered beneficial compounds. Given these findings, it might be worth considering that the trillions of microbes we host are not just passive residents but active producers of complex molecules, some of which could eventually help protect us from dangerous infections.